To Roche, a phase 3 flop in first-line breast cancer does not erase the megablockbuster potential of its oral SERD drug ...
PLEX100 would address a critical unmet medical need in the prevention of surgical site infections PDUFA target action date currently planned for the first quarter of 2027 PETACH TIKVA, Israel, June 01 ...
A 50-year-old Chinese national living in Buford, Georgia has admitted he helped wash millions in drug money through a ...
Newport Beach nonprofit CureDuchenne made a second investment in Tevard Biosciences to advance a protein-restoring therapy.
9don MSN
Incyte blood cancer drug combo reduces disease-progression risk but with high side-effect rate
By Christy Santhosh May 30 (Reuters) - Incyte's Monjuvi as part of a multi-drug regimen that includes a chemotherapy standard of care for an aggressive form of non-Hodgkin lymphoma reduced the risk of ...
Donald Trump's denaturalisation efforts target 17 individuals for alleged crimes, sparking controversy as critics mention ...
The International Criminal Court (ICC) judge presiding over former Philippine leader Rodrigo Duterte's crimes against ...
Gilead Sciences is maintained at 'Hold' as the HIV franchise drives growth, but the oncology pipeline requires further ...
NORTHSTAR will evaluate the efficacy and safety of investigational oral gildeuretinol, designed to reduce the formation of ...
Consumers should stop using the Wyze Solar Cam Pan cameras immediately and visit this website to see if your camera is ...
A New Drug Application for the investigational oral selective estrogen receptor degrader giredestrant has received Priority ...
Fulcrum Therapeutics said today it is scrapping its lead pipeline program to develop pociredir as a treatment for sickle cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results